Myoclonic disorders: a practical approach for diagnosis and treatment
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
Myoclonus is a sudden, brief, involuntary muscle jerk. It is caused by abrupt muscle contraction, in the case of positive myoclonus, or by sudden cessation of ongoing muscular activity, in the case of negative myoclonus (NM). Myoclonus may be classified in a number of ways, although classification based on the underlying physiology is the most useful from the therapeutic viewpoint. Given the large number of possible causes of myoclonus, it is essential to take a good history, to clinically characterize myoclonus and to look for additional findings on examination in order to limit the list of possible investigations. With regards to the history, the age of onset, the character of myoclonus, precipitating or alleviating factors, family history and associated symptoms and signs are important. On examination, it is important to see whether the myoclonus appears at rest, on keeping posture or during action, to note the distribution of jerks and to look for the stimulus sensitivity. Electrophysiological tests are very helpful in determining whether myoclonus is cortical, subcortical or spinal. A single pharmacological agent rarely control myoclonus and therefore polytherapy with a combination of drugs, often in large dosages, is usually needed. Generally, antiepileptic drugs such as valproate, levetiracetam and piracetam are effective in cortical myoclonus, but less effective in other forms of myoclonus. Clonazepam may be helpful with all types of myoclonus. Focal and segmental myoclonus, irrespective of its origin, may be treated with botulinum toxin injections, with variable success.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Shiang, R., Ryan, S. G., Zhu, Y.-Z., Hahn, A. F., O'Connell, P., & Wasmuth, J. J. (1993) · Nature Genetics · doi:10.1038/ng1293-351 · Cited by 543 · cited 2×
“Hyperekplexia may be familial as a result of mutation in the alpha1 subunit of the glycine receptor [Shiang et al. 1993], idiopathic or symptomatic of brainstem encephalitis, vascular lesions [Kimber and Thompson, 1997] or multiple sclerosis [Ruprecht et al. 2002].”
BackgroundMutations in the gene encoding ɛ-sarcoglycan cause myoclonus–dystonia syndrome
Zimprich, A., Grabowski, M., Asmus, F., Naumann, M., Berg, D., Bertram, M., Scheidtmann, K., Kern, P., Winkelmann, J., Müller-Myhsok, B., et al. (2001) · Nature Genetics · doi:10.1038/ng709 · Cited by 487 · cited 1×
“Approximately 50% of clinically definitive cases [Ritz et al. 2009] are due to mutations of the epsilon-sarcoglycan gene on chromosome 7q21 [Zimprich et al. 2001].”
BackgroundMyoclonus: current concepts and recent advances
Caviness, J. N., & Brown, P. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00880-4 · Cited by 375 · cited 10×
“Subcortical myoclonus Antiepileptic drugs used in cortical myoclonus are not effective in subcortical myoclonus [Caviness and Brown, 2004].”
BackgroundInfluentialElectrophysiological studies of myoclonus
Shibasaki, H., & Hallett, M. (2005) · Muscle & Nerve · doi:10.1002/mus.20234 · Cited by 302
SYMPTOMATIC AND ESSENTIAL RHYTHMIC PALATAL MYOCLONUS
DEUSCHL, G., MISCHKE, G., SCHENCK, E., SCHULTE-MÖNTING, J., & LÜCKING, C. H. (1990) · Brain · doi:10.1093/brain/113.6.1645 · Cited by 254 · cited 1×
“SPM is more common than EPM [Deuschl et al. 1990].”
BackgroundHallett, M., Chadwick, D., & Marsden, C. D. (1979) · Neurology · doi:10.1212/wnl.29.8.1107 · Cited by 246 · cited 1×
“Also, long loop reflexes mediated by the sensory motor cortex (C-reflexes) are enhanced and correspond to cortical reflex myoclonus [Hallett et al. 1979].”
BackgroundProgressive myoclonic epilepsies: a review of genetic and therapeutic aspects
Shahwan, A., Farrell, M., & Delanty, N. (2005) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70043-0 · Cited by 244 · cited 1×
“It is sensitive to touch, noise and light [Shahwan et al. 2005].”
BackgroundTHE HYPEREKPLEXIAS AND THEIR RELATIONSHIP TO THE NORMAL STARTLE REFLEX
BROWN, P., ROTHWELL, J. C., THOMPSON, P. D., BRITTON, T. C., DAY, B. L., & MARSDEN, C. D. (1991) · Brain · doi:10.1093/brain/114.4.1903 · Cited by 233
Segmental Myoclonus: Clinical and Pharmacologic Study
Jankovic, J. (1986) · Archives of Neurology · doi:10.1001/archneur.1986.00520100039012 · Cited by 201 · cited 1×
“Spinal segmental myoclonus is usually symptomatic of an underlying structural lesion such as syringomyelia, myelitis, spinal cord trauma, vascular lesion or malignancy [Brown et al. 1994; Jankovic and Pardo, 1986].”
BackgroundAdult-onset Alexander disease: a series of eleven unrelated cases with review of the literature
Pareyson, D., Fancellu, R., Mariotti, C., Romano, S., Salmaggi, A., Carella, F., Girotti, F., Gattellaro, G., Carriero, M. R., Farina, L., et al. (2008) · Brain · doi:10.1093/brain/awn178 · Cited by 189 · cited 4×
“PAPT may be sporadic or familial.”
BackgroundInfluential
Cited by
Network dysfunction in α‐synuclein transgenic mice and human Lewy body dementia
Morris, M., Sanchez, P. E., Verret, L., Beagle, A. J., Guo, W., Dubal, D., Ranasinghe, K. G., Koyama, A., Ho, K., Yu, G., et al. (2015) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.257 · Cited by 61
“We searched the charts for myoclonus and seizure disorders, both of which are thought to result from aberrant network excitability.(39,43,44) Myoclonus was noted in 21.”
Metadata
- Authors
- Kojovic, M., Cordivari, C., & Bhatia, K.
- Venue
- Therapeutic Advances in Neurological Disorders
- Publisher
- SAGE Publications
- Published
- 2011-01
- Volume
- 4
- Issue
- 1
- Pages
- 47-62
- ISSN
- 1756-2856 (ISSN-L)
- 1756-2864
- OpenAlex
- W2157863665
- Cited by
- 209
- References
- 50
- FWCI
- 5.71
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.